Systemic Therapy and Its Surgical Implications in Patients with Resectable Liver Colorectal Cancer Metastases. A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference
Shahid Ahmed(Emory University), Adnan Zaidi(University of Saskatchewan), Duc Le(University of Saskatchewan), Bryan Brunet(University of Saskatchewan), Janine Davies(BC Cancer Agency), Richard M. Lee‐Ying(Alberta Health Services), Howard Lim(BC Cancer Agency), John Paul McGhie(BC Cancer Agency), Christina Kim, Deepti Ravi(Saskatchewan Health Authority), Ralph Wong(CancerCare Manitoba), Michael Moser(University of Saskatchewan), Dorie-Anna Dueck(University of Saskatchewan), Devin Schellenberg(BC Cancer Agency), Daniel J. Renouf(BC Cancer Agency), Corinne Doll(Alberta Health), Nicholas Bosma(BC Cancer Agency), Karen Mulder(Alberta Health Services), Shuying Ji(Manitoba Health), Jason Park(University of Manitoba), Shahida Ahmed(CancerCare Manitoba)
Cited by 1
Related Papers
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17
|European Journal of Cancer|2015|337
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
|The Lancet Oncology|2018|216
HER2-directed therapy: current treatment options for HER2-positive breast cancer
|Breast Cancer|2015|183